5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies
5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies
Recruiting · NCT04187703 · Registry updated 2026-05-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| 5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies | Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Recruiting | Early phase 1 | 2026-05-18 | NCT04187703 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Benjamin Tomlinson | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center | Cleveland | United States | 1 |